UM
Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice
Sun F.1; Zhang Z.W.1; Tan E.M.1; Lim Z.L.R.1; Li Y.1; Wang X.C.1; Chua S.E.1; Li J.1; Cheung E.2; Yong E.-L.1
2016-07-01
Source PublicationCarcinogenesis
ISSN14602180 01433334
Volume37Issue:7Pages:701-711
AbstractNeuroendocrine prostate cancer (NEPC) has a poor prognosis, with a median survival of less than 1 year after diagnosis. Following androgen deprivation therapy, prostate adenocarcinoma cells have been observed to develop an androgen receptor-negative, terminally differentiated and indolent neuroendocrine-like phenotype. However, several molecular events, including interleukin 6 (IL-6) stimulation, in the prostate microenvironment result in the appearance of aggressive, highly proliferative castrate-resistant NEPC. In this study, we examined the mechanistic effects of a natural prenylflavonoid, icaritin (ICT), on neuroendocrine differentiation in IL-6-induced LNCaP cells and NEPC development in the male transgenic adenocarcinoma of the mouse prostate (TRAMP) model. TRAMP mice received daily intraperitoneal injection of ICT or vehicle. ICT induced apoptosis in prostate tumor, suppressed NEPC development and, accordingly, improved overall survival in TRAMP mice. Expression of neuroendocrine markers (synaptophysin) and androgen receptor in TRAMP mice and neuroendocrine-like LNCaP cells were inhibited by ICT. Suppression of neuroendocrine and NEPC development by ICT was associated with dose-dependent inhibitory effects on abnormally elevated IL-6/STAT3 and Aurora kinase A in vitro and in vivo. Since ICT demonstrated favorable pharmacokinetic and safety profiles with marked enrichment in prostate tissues, our study provides evidence for the development of prenylflavonoid as a multimodal therapeutic agent against NEPC.
DOI10.1093/carcin/bgw044
URLView the original
Language英語
Fulltext Access
Citation statistics
Cited Times [WOS]:12   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.Yong Loo Lin School of Medicine
2.Universidade de Macau
Recommended Citation
GB/T 7714
Sun F.,Zhang Z.W.,Tan E.M.,et al. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice[J]. Carcinogenesis,2016,37(7):701-711.
APA Sun F..,Zhang Z.W..,Tan E.M..,Lim Z.L.R..,Li Y..,...&Yong E.-L..(2016).Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.Carcinogenesis,37(7),701-711.
MLA Sun F.,et al."Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice".Carcinogenesis 37.7(2016):701-711.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Sun F.]'s Articles
[Zhang Z.W.]'s Articles
[Tan E.M.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Sun F.]'s Articles
[Zhang Z.W.]'s Articles
[Tan E.M.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Sun F.]'s Articles
[Zhang Z.W.]'s Articles
[Tan E.M.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.